<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>E273 - Busting Myths About Antidepressants with Dr. Jeffrey Strawn</title>
  <description> In this episode, Dr. Andy Cutler and Dr. Jeff Strawn unpack common misconceptions that complicate real-world use of antidepressants. They review evidence on efficacy, suicidality risk, mechanisms, and early side effects, and discuss how to navigate hesitancy and misinformation. The conversation also addresses when to start medication, how to balance caution with&amp;amp;nbsp;timely&amp;amp;nbsp;intervention in youth, and practical ways to strengthen trust and therapeutic alliance.&amp;amp;nbsp;   Jeffrey R. Strawn, MD, FAACAP,&amp;amp;nbsp;is a Professor of Psychiatry, Pediatrics, and Clinical &amp;amp;amp; Translational Pharmacology at the University of Cincinnati (UC) in Cincinnati, Ohio. He is the Director of the UC Anxiety Disorders Research Program and the Associate Vice Chair of Research in the Department of Psychiatry &amp;amp;amp; Behavioral Neuroscience at UC. &amp;amp;nbsp;   Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute&amp;amp;nbsp;and EMA Wellness.&amp;amp;nbsp;He is a&amp;amp;nbsp;Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.&amp;amp;nbsp;   Resources&amp;amp;nbsp;   Zhang K et al.&amp;amp;nbsp;Functional&amp;amp;nbsp;connectivity predicting transdiagnostic treatment outcomes in internalizing psychopathologies. JAMA&amp;amp;nbsp;Netw&amp;amp;nbsp;Open 2025;8(9):e2530008.&amp;amp;nbsp;doi:&amp;amp;nbsp;10.1001/jamanetworkopen.2025.30008&amp;amp;nbsp;   Lagerberg T et al.&amp;amp;nbsp;Selective serotonin reuptake inhibitors and suicidal&amp;amp;nbsp;behaviour: a population-based cohort study. Neuropsychopharmacology 2022;47(4):817-23.&amp;amp;nbsp;doi:&amp;amp;nbsp;10.1038/s41386-021-01179-z&amp;amp;nbsp; Never miss an  episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite platforms:&amp;amp;nbsp;https://nei.global/podcast&amp;amp;nbsp;  Interested in Psychopharmacology?&amp;amp;nbsp;&amp;amp;nbsp;Learn about the NEI Master Psychopharmacology Program:&amp;amp;nbsp;https://nei.global/mpp&amp;amp;nbsp;&amp;amp;nbsp;   Stay updated with&amp;amp;nbsp;email alerts&amp;amp;nbsp;and join our conversations on&amp;amp;nbsp;social. Follow us on:&amp;amp;nbsp;     YouTube:&amp;amp;nbsp;https://nei.global/youtube&amp;amp;nbsp;       Instagram:&amp;amp;nbsp;https://nei.global/instagram&amp;amp;nbsp;       LinkedIn:&amp;amp;nbsp;https://nei.global/linkedin&amp;amp;nbsp;       Facebook:&amp;amp;nbsp;https://nei.global/facebook&amp;amp;nbsp;       X:&amp;amp;nbsp;https://nei.global/twitter&amp;amp;nbsp;     </description>
  <author_name>NEI Podcast</author_name>
  <author_url>http://neiglobal.libsyn.com/website</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39470585/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/196724585</thumbnail_url>
</oembed>
